Stock Analysis on Net
Stock Analysis on Net

Lam Research Corp. (NASDAQ:LRCX)

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

Lam Research Corp., common-size consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

Microsoft Excel
Sep 29, 2024 Jun 30, 2024 Mar 31, 2024 Dec 24, 2023 Sep 24, 2023 Jun 25, 2023 Mar 26, 2023 Dec 25, 2022 Sep 25, 2022 Jun 26, 2022 Mar 27, 2022 Dec 26, 2021 Sep 26, 2021 Jun 27, 2021 Mar 28, 2021 Dec 27, 2020 Sep 27, 2020 Jun 28, 2020 Mar 29, 2020 Dec 29, 2019 Sep 29, 2019 Jun 30, 2019 Mar 31, 2019 Dec 23, 2018 Sep 23, 2018
Trade accounts payable 3.61 3.28 2.91 2.66 2.85 2.51 3.13 4.79 6.12 5.88 6.07 5.71 5.38 5.22 4.98 4.70 4.40 4.07 3.86 3.80 3.37 3.14 3.23 3.19 3.51
Accrued expenses and other current liabilities 11.24 9.61 9.80 10.52 11.44 10.71 10.34 10.77 10.41 11.48 9.86 10.61 10.50 10.82 8.45 9.62 8.86 8.74 7.92 9.35 8.02 7.89 8.12 11.18 12.30
Deferred profit 9.92 7.56 8.76 9.55 8.60 9.03 9.57 8.08 10.42 9.14 9.31 6.80 5.98 6.09 4.80 3.62 3.83 3.14 4.17 3.08 3.29 3.18 2.93 4.01 4.95
Current portion of long-term debt and finance lease obligations 2.58 2.69 2.76 0.02 0.02 0.04 0.04 0.04 0.04 0.04 0.05 0.04 0.04 0.07 5.40 5.42 5.54 5.77 0.33 5.31 5.23 5.56 7.48 1.74 5.02
Current liabilities 27.35% 23.14% 24.24% 22.74% 22.91% 22.28% 23.08% 23.67% 26.99% 26.55% 25.29% 23.15% 21.90% 22.20% 23.63% 23.36% 22.63% 21.72% 16.27% 21.53% 19.91% 19.76% 21.76% 20.12% 25.78%
Long-term debt and finance lease obligations, less current portion 22.93 23.89 24.50 26.51 26.87 26.64 25.97 26.01 26.69 29.07 30.14 29.90 32.05 31.40 32.66 32.48 33.16 34.14 38.98 31.78 30.69 31.85 29.48 16.84 16.47
Income taxes payable 3.40 4.34 4.55 4.25 4.21 4.70 4.60 4.49 4.49 5.41 5.53 5.34 5.66 5.97 6.05 5.87 5.84 6.25 6.87 7.33 6.94 7.44 6.69 7.98 7.72
Other long-term liabilities 2.94 3.07 2.83 2.72 2.61 2.67 2.66 2.58 2.24 2.46 2.72 2.80 2.99 2.51 2.50 2.45 2.33 2.28 2.71 2.28 2.12 1.59 0.65 0.82 0.91
Long-term liabilities 29.27% 31.30% 31.88% 33.48% 33.68% 34.00% 33.23% 33.09% 33.41% 36.94% 38.39% 38.04% 40.71% 39.88% 41.20% 40.80% 41.34% 42.68% 48.57% 41.39% 39.75% 40.88% 36.82% 25.63% 25.11%
Total liabilities 56.63% 54.44% 56.11% 56.23% 56.59% 56.29% 56.31% 56.76% 60.41% 63.49% 63.67% 61.19% 62.61% 62.07% 64.84% 64.16% 63.97% 64.40% 64.84% 62.92% 59.66% 60.64% 58.58% 45.75% 50.89%
Temporary equity, convertible notes 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.04 0.04 0.08 0.09 0.32 0.34 0.41 0.39 0.53 0.54
Preferred stock, at par value of $0.001 per share; none outstanding 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Common stock, at par value of $0.001 per share 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Additional paid-in capital 42.51 43.88 44.21 42.58 42.50 41.58 39.91 39.60 40.02 43.12 43.94 43.27 45.69 44.38 45.29 44.60 44.91 45.99 50.84 54.80 52.31 53.41 48.98 58.10 56.54
Treasury stock, at cost -129.91 -129.99 -131.21 -122.47 -120.65 -114.64 -107.19 -104.51 -104.65 -113.29 -112.22 -103.65 -108.34 -98.46 -99.53 -91.97 -89.11 -88.95 -99.85 -106.37 -94.63 -96.68 -81.50 -88.90 -87.45
Accumulated other comprehensive loss -0.45 -0.70 -0.70 -0.63 -0.65 -0.54 -0.55 -0.57 -0.71 -0.64 -0.59 -0.53 -0.53 -0.40 -0.41 -0.37 -0.55 -0.65 -0.87 -0.51 -0.59 -0.53 -0.49 -0.60 -0.53
Retained earnings 131.22 132.36 131.58 124.29 122.21 117.31 111.52 108.71 104.93 107.32 105.20 99.71 100.56 92.40 89.80 83.54 80.74 79.13 84.95 88.84 82.90 82.75 74.04 85.11 80.02
Stockholders’ equity 43.37% 45.56% 43.89% 43.77% 43.41% 43.71% 43.69% 43.24% 39.59% 36.51% 36.33% 38.81% 37.39% 37.93% 35.14% 35.80% 35.99% 35.53% 35.07% 36.76% 39.99% 38.94% 41.03% 53.72% 48.58%
Total liabilities and stockholders’ equity 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-Q (reporting date: 2024-09-29), 10-K (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-Q (reporting date: 2023-12-24), 10-Q (reporting date: 2023-09-24), 10-K (reporting date: 2023-06-25), 10-Q (reporting date: 2023-03-26), 10-Q (reporting date: 2022-12-25), 10-Q (reporting date: 2022-09-25), 10-K (reporting date: 2022-06-26), 10-Q (reporting date: 2022-03-27), 10-Q (reporting date: 2021-12-26), 10-Q (reporting date: 2021-09-26), 10-K (reporting date: 2021-06-27), 10-Q (reporting date: 2021-03-28), 10-Q (reporting date: 2020-12-27), 10-Q (reporting date: 2020-09-27), 10-K (reporting date: 2020-06-28), 10-Q (reporting date: 2020-03-29), 10-Q (reporting date: 2019-12-29), 10-Q (reporting date: 2019-09-29), 10-K (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-Q (reporting date: 2018-12-23), 10-Q (reporting date: 2018-09-23).

Balance sheet item Description The company
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Lam Research Corp. current liabilities as a percentage of total liabilities and stockholders’ equity decreased from Q3 2024 to Q4 2024 but then increased from Q4 2024 to Q1 2025 exceeding Q3 2024 level.
Long-term liabilities Amount of obligation due after one year or beyond the normal operating cycle, if longer. Lam Research Corp. long-term liabilities as a percentage of total liabilities and stockholders’ equity decreased from Q3 2024 to Q4 2024 and from Q4 2024 to Q1 2025.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Lam Research Corp. total liabilities as a percentage of total liabilities and stockholders’ equity decreased from Q3 2024 to Q4 2024 but then increased from Q4 2024 to Q1 2025 exceeding Q3 2024 level.
Stockholders’ equity Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Lam Research Corp. stockholders’ equity as a percentage of total liabilities and stockholders’ equity increased from Q3 2024 to Q4 2024 but then decreased significantly from Q4 2024 to Q1 2025.